Pyrrole adducts in globin and plasma of workers exposed to hexane.


Journal

International archives of occupational and environmental health
ISSN: 1432-1246
Titre abrégé: Int Arch Occup Environ Health
Pays: Germany
ID NLM: 7512134

Informations de publication

Date de publication:
08 2019
Historique:
received: 09 04 2018
accepted: 03 04 2019
pubmed: 8 4 2019
medline: 23 1 2020
entrez: 8 4 2019
Statut: ppublish

Résumé

Urinary excretion of 2,5-hexanedione is currently used to estimate the exposure levels of hexane occurring to an individual during the previous work shift. However, because hexane exposures and urinary 2,5-hexanedione levels can vary considerably from day to day, and subchronic to chronic exposures to hexane are required to produce neuropathy, this biomarker may not accurately reflect the risk of an individual for developing hexane neuropathy. This investigation examines the potential of hexane-derived pyrrole adducts produced on globin and plasma proteins as markers for integrating cumulative exposures. Because the pyrrole markers incorporate bioactivation of hexane to 2,5-hexandione and the initial step of protein adduction involved in hexane-induced neuropathy, they potentially can serve as biomarkers of effect through reflecting pathogenetic events within the nervous system. Additionally, pyrrole formation is an irreversible reaction suggesting that hexane-derived protein pyrroles can be used to assess cumulative exposures to provide a better characterization of individual susceptibilities. To examine the utility of the proposed markers, blood samples were obtained from eleven workers who used hexane for granulating metal powders in a slurry to produce metal machining die tools and four non-exposed volunteers. Globin and plasma were isolated, and the proteins were digested using pepsin, reacted with Ehrlich's reagent and the level of pyrrole adducts were determined by absorbance at 530 nm. To determine the dose-response curve and dynamic range of the assay, erythrocytes were incubated with a range of 2,5-hexanedione concentrations and the net absorbance at 530 nm of isolated globin was measured. Pyrrole was detected in both the globin and plasma samples of the workers exposed to hexane and the levels of pyrroles in plasma were positively correlated with the levels of pyrroles in globin for most of the workers. This investigation demonstrates that detectable levels of hexane-derived protein pyrrole adducts are produced on peripheral proteins following occupational exposures to hexane and supports the utility of measuring pyrroles for integrating cumulative exposures to hexane.

Identifiants

pubmed: 30955093
doi: 10.1007/s00420-019-01430-7
pii: 10.1007/s00420-019-01430-7
doi:

Substances chimiques

Biomarkers 0
Hexanes 0
Pyrroles 0
Globins 9004-22-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-881

Références

Med J Osaka Univ. 1977 Sep;28(1):77-85
pubmed: 207957
Int Arch Occup Environ Health. 2014 Aug;87(6):655-62
pubmed: 24078145
Toxicol Appl Pharmacol. 1982 Sep 30;65(3):440-50
pubmed: 7157375
Chem Res Toxicol. 1988 May-Jun;1(3):179-85
pubmed: 2979729
PLoS One. 2013 Sep 30;8(9):e76011
pubmed: 24098756
Toxicol Appl Pharmacol. 1987 May;88(3):383-96
pubmed: 3576623
Toxicol Appl Pharmacol. 1988 Jan;92(1):75-85
pubmed: 3341029
PLoS One. 2014 Jan 22;9(1):e86108
pubmed: 24465904
Clin Toxicol. 1981 Dec;18(12):1395-402
pubmed: 6277550
Br J Ind Med. 1980 Aug;37(3):241-7
pubmed: 7426474
Toxicol Appl Pharmacol. 1983 Apr;68(2):297-307
pubmed: 6857666
Neurotoxicology. 1987 Spring;8(1):199-210
pubmed: 3550536
Int Arch Occup Environ Health. 1991;63(4):285-91
pubmed: 1743771
Neurotoxicology. 2002 Dec;23(6):747-54
pubmed: 12520764
Toxicol In Vitro. 1995 Oct;9(5):783-7
pubmed: 20650157
Arch Toxicol. 1990;64(3):242-6
pubmed: 2196864
Folia Psychiatr Neurol Jpn. 1969;23(1):45-57
pubmed: 5820368
Neurotoxicology. 1998 Feb;19(1):99-107
pubmed: 9498226
J Toxicol Environ Health A. 2009;72(14):861-9
pubmed: 19557614
Arch Toxicol. 1987;60(1-3):77-80
pubmed: 3619648
Chem Res Toxicol. 1994 Jul-Aug;7(4):551-8
pubmed: 7981420
Chem Res Toxicol. 1995 Jul-Aug;8(5):764-71
pubmed: 7548760
Neurotoxicology. 1985 Winter;6(4):55-63
pubmed: 3937075
Mol Pharmacol. 1986 Nov;30(5):452-8
pubmed: 3773883
Toxicol Appl Pharmacol. 1982 Jul;64(3):415-22
pubmed: 6814014
Arch Toxicol. 1990;64(2):165-8
pubmed: 2350238

Auteurs

Gaku Ichihara (G)

Department of Occupational and Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. gak@rs.tus.ac.jp.

Venkataraman Amarnath (V)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Holly L Valentine (HL)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Tatsuya Takeshita (T)

Department of Public Health, Wakayama Medical University, Wakayama, Japan.

Kanehisa Morimoto (K)

Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Tomotaka Sobue (T)

Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Toshio Kawai (T)

Osaka Occupational Health Service Center, Osaka, Japan.

William M Valentine (WM)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH